Profound Medical Corp (NASDAQ:PROF) currently has a daily average trading volume of 65.91K but it saw 82284 shares traded in last market. With a market cap of 230.63M USD, the company’s current market price of $7.68 came rising about 0.26 while comparing to the previous closing price of $7.66. In past 52 weeks, the stock remained buoying in the range of price level as high as $11.42 and as low as $6.78. In the recent trading on the day, stock has struck highest price mark of $7.585 while lowest mark touched by it was $7.88.
Taking a look at 20-day trading activity of Profound Medical Corp (PROF) gives us an average price of $7.39, while its current price level is -32.75% below from 52-week high level whereas it is 13.27% above from lowest level seen by the stock during that period. Simple moving average of 50 days or SMA-50 of the stock’s closing price is $7.70 while that of 200 days or SMA-200 reads an average of $8.25. A closer look into the stock’s movement over the week reveals that its volatility is standing at 4.52% during that period while stretching the period over a month that increases to 5.14%. It is also necessary to take a look into other indicators of a stock too, to get a better idea about its price movement. And in doing so, we find stock’s 14-day relative strength index (RSI) standing at 53.16 which implies that the stock is in neutral territory.
The company’s shares got several price updates from the analyst firms in past one month and most recent of them is from the Lake Street which initiated the stock as “Buy” in its note to investors issued on July 23, 2024, recommending a price target of $16.50 for it. Stifel upgraded its recommendation for the stock as a “Buy” from “Hold” on July 16, 2024 while assigning a price target range of $9-$12. Stifel also issued its recommendations for the stock as it initiated the price target for the stock is $11.
Over the week, PROF’s stock price is moving 2.26% up while it is 2.54% when we observe its performance for the past one month. Year-to-date it is 2.26% up and over the past year, the stock is showing an upside performance of 1.45%.
The company is expected to be releasing its next quarterly report in February, for which analysts forecasted an EPS of -0.34 while estimate for next year EPS is -1.25. In next quarter, company is expected to be making quarterly sales of $6.55M as analysts are expecting the sales for current fiscal year at $15.8M and seeing the company making $37.96M in sales next year. Moreover, analysts are in estimates of $5.92M for current-quarter revenue.
Currently, Profound Medical Corp’s total number of outstanding shares is 30.03M. Company’s return on investment (ROI) stands at -90.13% and return on equity (ROE) at -90.17%. Stock’s beta reads 0.90. Stock has a price to book (P/B) ratio of 6.10 while price to sale or P/S ratio amounts to 25.68. Its return on asset (ROA) is -67.74% on average.
